SEEMA ANTONY: Open Payments
NPI 1457914657 · DAVENPORT, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$461 in 24 payments from 12 companies in 2025. Trend: 2023 $525 · 2024 $442 · 2025 $461
Food & beverage: $461
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $89 |
| E.R. Squibb & Sons, L.L.C. | 3 | $85 |
| Alkermes, Inc. | 3 | $50 |
| Lundbeck LLC | 3 | $46 |
| Neurocrine BioSciences, Inc. | 2 | $39 |
| Teva Pharmaceuticals USA, Inc. | 2 | $33 |
| Otsuka America Pharmaceutical, Inc. | 2 | $27 |
| Corium, LLC | 1 | $20 |
| Almatica Pharma LLC | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $19 |
Products named: VRAYLAR, COBENFY, REXULTI, INGREZZA, ARISTADA, ABILIFY ASIMTUFII, Azstarys, LOREEV XR.
Industry payments across IA — which companies pay providers there.
